Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GEBERTH, Matthias")

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 4 of 4

  • Page / 1
Export

Selection :

  • and

Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer : A randomized trial (GABG-IV D-93)-The German adjuvant breast cancer groupKAUFMANN, Manfred; GRAF, Erika; SCHUMACHER, Martin et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7842-7848, issn 0732-183X, 7 p.Article

Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2GNANT, Michael; BASELGA, Jose; GEBERTH, Matthias et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 9, pp 654-663, issn 0027-8874, 10 p.Article

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer : GABG-IV B-93KAUFMANN, Manfred; GRAF, Erika; VON MINCKWITZ, Gunter et al.European journal of cancer (1990). 2007, Vol 43, Num 16, pp 2351-2358, issn 0959-8049, 8 p.Article

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients : A randomised trial (GABG trial IV-A-93)VON MINCKWITZ, Gunter; GRAF, Erika; KAUFMANN, Manfred et al.European journal of cancer (1990). 2006, Vol 42, Num 12, pp 1780-1788, issn 0959-8049, 9 p.Article

  • Page / 1